| | | FEPRAZONE CAS:30748-29-9 Trade Name: 4-(3-methylbut-2-enyl)-1,2-diphenylpyrazolidine-3,5-dione Formula: C20H20N2O2 APS30748299 320.38 Methrazone, Metrazone, Pheprazone, 4-(3-Methyl-2-butenyl)-1,2-diphenyl-3,5-pyrazolidinedione, Feprazone, Fenilprenazone, Prenazone,3,5-Pyrazolidinedione, 4-(3-methyl-2-buten-1-yl)-1,2-diphenyl-, Analud, 4-(2-Isopentenyl)-1,2-diphenyl-3,5-py FERN-7-EN-19-ONE CAS:222294-61-3 Trade Name: (3R,3aR,5aS,7aS,11aS,11bR,13aS,13bR)-3a,5a,8,8,11a,13a-hexamethyl-3-propan-2-yl-3,4,5,7,7a,9,10,11,1 Formula: C30H48O ACM222294613 424.71 Ferrate(2-),[7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-kn21,kn22,kn23,kn24]-,(sp-4-2)-(9ci) CAS:104414-01-9 Formula: C34H30FeN4O4 ACM104414019 Ferrate(3-),[(7S,8S)-3-carboxy-5-(carboxymethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphine-7-propanoato(5-)-kn21,kn22,kn23,kn24]-,trisodium,(sp-4-2)-(9ci) CAS:69138-22-3 Formula: C34H31FeN4O6.3Na ACM69138223 FERRIC AMMONIUM EDTA CAS:21265-50-9 Formula: C10H16FeN3O8 ACM21265509 362.09 [[N,N'-1,2-ethanediylbis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']-,ammonium,(OC-6-2Ferrate(1-);ammoniumiron(iii)ethylenediaminetetraacetate;Ethlenediaminetetraaceticacidferricammoniumsalt;Ethylenediaminetetraceticacid,ferricammoni FERRIC DERISOMALTOSE CAS:1345510-43-1 Trade Name: iron(3+);(2S,3R,4R,5R)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6- Formula: C18H34FeO16+3 PR1345510431 562.3 (1-6)-alpha-D-Glucan reduced reaction products with iron hydroxide FERRIC PERCHLORATE, HYDRATED, NON-YELLOW CAS:55144-08-6 Formula: Cl3FeH12O18 ACM55144086 462.29 FERRIC PERCHLORATE, HYDRATED, NON-YELLOW;FERRIC PERCHLORATE, HYDRATED, YELLOW;IRON(III) PERCHLORATE HEXAHYDRATE;FERRIC PERCHLORATE, HYDRATED, NON-YELLOW REAGENT;FERRIC PERCHLORATE, HYDRATED, YELLOW REAGENT FERRIC(III)HEXAFLUOROACETYLACETONATE CAS:17786-67-3 Trade Name: 1,1,1,5,5,5-hexafluoropentane-2,4-dione; iron Formula: C15H3F18FeO6 ACM17786673 677 Tris(hexafluoroacetylacetonato)iron, NSC177690, Iron, tris(1,1,1,5,5,5-hexafluoroacetylacetonato)-, Iron, tris(1,1,1,5,5,5-hexafluoro-2,4-pentanedionato)-, Iron, tris(1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O)-, (OC-6-11)-, 17786-67-3 Ferrocene,1-(dicyclohexylphosphino)-2-[(1R)-1-(dicyclohexylphosphino)ethyl]-,(1R)- CAS:167416-28-6 Trade Name: cyclopentane;dicyclohexyl-[(1R)-1-(2-dicyclohexylphosphanylcyclopentyl)ethyl]phosphane;iron Formula: C36H56FeP2 ACM167416286 606.62 Josiphos SL-J003-1, (R)-1-[(SP)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldicyclohexylphosphine, 167416-28-6, 88721_ALDRICH, CTK8E6530, 36676_SIAL, SC11421, (R)-(-)-1-[(S)-2-(dicyclohexylphosphino)ferrocenyl]ethyldicyclohexylphosphine, (R)-1 FERROIN CAS:14634-91-4 Formula: C36H24FeN6.O4S APS14634914 692.52 Iron(2+), tris(1,10-phenanthroline-N1,N10)-, (OC-6-11)-, sulfate (1:1), Tris(1,10-phenanthroline)iron(II) sulfate, Tris(1,10-phenanthroline)iron sulfate (6CI,7CI),Iron(2+), tris(1,10-phenanthroline-+¦N1,+¦N10)-, (OC-6-11)-, sulfate (1:1), Fer FERROUS GLUCONATE CAS:299-29-6 Trade Name: iron(2+);(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate Formula: 2C6H11O7.Fe APS299296 446.14 Ferrous Gluconate, Ferrous gluconate, Ferrum Polon, Ray-Gluciron, Iron gluconate, Entron, Cerevon, Ferrin 55, Ferroglyconicum, Nionate, Bis(D-gluconato-+¦O1,+¦O2)iron, Gluco-Ferrum, Iromon, Bis(D-gluconato-O1,O2)iron, D-Gluconic acid, iron co FERRUGINOL CAS:514-62-5 Trade Name: (4bS,8aS)-4b,8,8-trimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-3-ol Formula: C20H30O FFC-AR-514625 286.45 (+)-8,11,13-Abietatrien-12-ol FERULENOL CAS:6805-34-1 Trade Name: 4-hydroxy-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]chromen-2-one Formula: C24H30O3 FFC-AR-6805341 366.49 4-hydroxy-3-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]-2H-1-benzopyran-2-one FERULIC ACID IMPURITY 18 CAS:98942-06-4 Formula: C33H40O18 APB98942064 724.66 (E)-(2R,3S,4R,5R)-4-hydroxy-2-((((E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acryloyl)oxy)methyl)-5-(hydroxymethyl)-2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydrofuran-3-yl 3-(4-hydroxy-3-methoxyphen FERUTININ CAS:41743-44-6 Trade Name: [(3R,3aS,4S,8aR)-3-hydroxy-6,8a-dimethyl-3-propan-2-yl-1,2,3a,4,5,8-hexahydroazulen-4-yl] 4-hydroxyb Formula: C22H30O4 FFC-AR-41743446 358.47 4-hydroxy-benzoic acid, (3R,3aS,4S,8aR)-1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-6,8a-dimethyl-3-(1-methylethyl)-4-azulenyl ester Fetal-tau Protein, Human, Recombinant (His) RHC-OTH-0035 38.7 kDa (predicted); 40-50 kDa (reducing conditio TAU, PPP1R103, PPND, MTBT2, MTBT1, MSTD, microtubule-associated protein tau, MAPTL, MAPT, FTDP-17, DDPAC FGFR1 beta (IIIc) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2613 25.23 kDa (predicted). Due to glycosylation, the p N-sam, FLT-2, FGFR1 +¦ (IIIc), FGFR-1, CD331, bFGF-R-1, BFGFR FGFR1 Protein, Human, Recombinant (alpha (IIIb), hFc) RHC-CD-2713 65.7 kDa (predicted); 113.3 kDa (reducing conditio OGD, N-SAM, KAL2, HRTFDS, HH2, HBGFR, FLT-2, FLT2, FLG, fibroblast growth factor receptor 1, FGFR1 +¦ (IIIc), FGFR-1, FGFBR, CEK, CD331, bFGF-R-1, BFGFR FGFR1 Protein, Human, Recombinant (alpha (IIIb), His) RHC-CD-2598 40.5 kDa (predicted); 60-90 kDa (reducing conditio OGD, N-SAM, KAL2, HRTFDS, HH2, HBGFR, FLT-2, FLT2, FLG, fibroblast growth factor receptor 1, FGFR1 +¦ (IIIc), FGFR-1, FGFBR, CEK, CD331, bFGF-R-1, BFGFR FGFR1 Protein, Human, Recombinant (beta (IIIb), hFc) RHC-CD-2606 56 kDa (predicted); 76-106 kDa (reducing condition OGD, N-SAM, KAL2, HRTFDS, HH2, HBGFR, FLT-2, FLT2, FLG, fibroblast growth factor receptor 1, FGFR-1, FGFBR, CEK, CD331, bFGF-R-1, BFGFR FGFR1 Protein, Human, Recombinant (beta (IIIb), His) RHC-CD-2534 30.8 kDa (predicted); 45-60 kDa (reducing conditio OGD, N-SAM, KAL2, HRTFDS, HH2, HBGFR, FLT-2, FLT2, FLG, fibroblast growth factor receptor 1, FGFR-1, FGFBR, CEK, CD331, bFGF-R-1, BFGFR FGFR1 Protein, Human, Recombinant (hFc) RHC-CD-2679 56.15 kDa (predicted) OGD, N-SAM, KAL2, HRTFDS, HH2, HBGFR, FLT-2, FLT2, FLG, fibroblast growth factor receptor 1, FGFR-1, FGFBR, CEK, CD331, bFGF-R-1, BFGFR FGFR1 Protein, Human, Recombinant (His & GST) RHC-CD-2709 75 kDa (predicted); 75 kDa (reducing conditions) OGD, N-SAM, KAL2, HRTFDS, HH2, HBGFR, FLT-2, FLT2, FLG, fibroblast growth factor receptor 1, FGFR-1, FGFBR, CEK, CD331, bFGF-R-1, BFGFR FGFR1 Protein, Human, Recombinant (His) RHC-CD-2782 31 kDa (predicted); 50-55 kDa (reducing condition, OGD, N-SAM, KAL2, HRTFDS, HH2, HBGFR, FLT-2, FLT2, FLG, fibroblast growth factor receptor 1, FGFR-1, FGFBR, CEK, CD331, bFGF-R-1, BFGFR FGFR1 Protein, Human, Recombinant (His), Biotinylated RHC-CD-2714 31 kDa (predicted) OGD, N-SAM, KAL2, HRTFDS, HH2, HBGFR, FLT-2, FLT2, FLG, fibroblast growth factor receptor 1, FGFR-1, FGFBR, CEK, CD331, bFGF-R-1, BFGFR FGFR1 Protein, Mouse, Recombinant (hFc) RHC-CD-2722 66.5 kDa (predicted); 100-110 kDa (reducing condit MFR, Hspy, Flt-2, FLG, fibroblast growth factor receptor 1, Fgfr-1, Eask, c-fgr, bFGF-R-1, AW208770 FGFR1 Protein, Mouse, Recombinant (His) RHC-CD-2718 40.9 kDa (predicted); 55-65 kDa (reducing conditio MFR, Hspy, Flt-2, FLG, fibroblast growth factor receptor 1, Fgfr-1, Eask, c-fgr, bFGF-R-1, AW208770 FGFR2 alpha (IIIb) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2570 42.5 kDa (predicted). Due to glycosylation, the pr TK25, TK14, K-SAM, KGFR, JWS, FLJ98662, FGFR2 +¦ (IIIb), FGFR2 +¦, FGFR2 alpha, FGF R2a, ECT1, CFD1, CEK3, CD332, BFR-1, BEK, BBDS FGFR2 alpha (IIIc) Protein, Human, Recombinant (hFc) RHC-CD-2757 72-95 kDa (reducing condition) FGFR2IIIc, FGFR2b, FGFR2 +¦, FGFR2 +¦ (IIIc), FGFR2 beta, FGFR2, FGF R2b, CD332, BEK FGFR2 alpha (IIIc) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2699 42.5 kDa (predicted). Due to glycosylation, the pr TK25, TK14, K-SAM, KGFR, JWS, FLJ98662, FGFR2 +¦ (IIIc), FGFR2 +¦, FGFR2 alpha, FGF R2a, ECT1, CFD1, CEK3, CD332, BFR-1, BEK, BBDS FGFR2 beta (IIIb) Domain Protein, Human, Recombinant (Avi) RHC-CD-2553 15.49 kDa (predicted). Due to glycosylation, the p K-sam, KSAM, KGFR, Keratinocyte growth factor receptor, Fibroblast growth factor receptor 2, FGFR2 +¦ (IIIb) Domain Protein, FGFR-2, CD332, BEK FGFR2 beta (IIIb) Domain Protein, Human, Recombinant (Avi), Biotinylated RHC-CD-2669 15.49 kDa (predicted). Due to glycosylation, the p K-sam, KSAM, KGFR, Keratinocyte growth factor receptor, Fibroblast growth factor receptor 2, FGFR2 +¦ (IIIb) Domain Protein, FGFR-2, CD332, BEK FGFR2 beta (IIIb) Protein, Cynomolgus, Recombinant (His) RHC-CD-2755 26.2 kDa (predicted). Due to glycosylation, the pr K-sam, KSAM, KGFR, Keratinocyte growth factor receptor, Fibroblast growth factor receptor 2, FGFR2 +¦ (IIIb), FGFR-2, CD332, BEK FGFR2 beta (IIIb) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2701 28.3 kDa (predicted). Due to glycosylation, the pr K-sam, KSAM, KGFR, Keratinocyte growth factor receptor, Fibroblast growth factor receptor 2, FGFR2 +¦ (IIIb), FGFR-2, CD332, BEK FGFR2 beta (IIIb) Protein, Mouse, Recombinant (His) RHC-ENZY-0460 26.3 kDa (predicted). Due to glycosylation, the pr K-sam, KSAM, KGFR, Keratinocyte growth factor receptor, Fibroblast growth factor receptor 2, FGFR2 +¦ (IIIb), FGFR-2, CD332, BEK FGFR2 beta (IIIc) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2754 28.2 kDa (predicted). Due to glycosylation, the pr K-sam, KSAM, KGFR, Keratinocyte growth factor receptor, Fibroblast growth factor receptor 2, FGFR2 +¦ (IIIc), FGFR-2, CD332, BEK FGFR2 Protein, Human, Recombinant (aa 1-377, His) RHC-CD-2673 41 kDa (predicted); 65-75 kDa (reducing condition, TK25, TK14, K-SAM, KGFR, JWS, fibroblast growth factor receptor 2, ECT1, CFD1, CEK3, CD332, BFR-1, BEK, BBDS FGFR2 Protein, Human, Recombinant (aa 1-378, His) RHC-CD-2774 41.1 kDa (predicted) TK25, TK14, K-SAM, KGFR, JWS, fibroblast growth factor receptor 2, ECT1, CFD1, CEK3, CD332, BFR-1, BEK, BBDS FGFR2 Protein, Human, Recombinant (aa 400-821, His & GST) RHC-CD-2775 75.7 kDa (predicted); 68 kDa (reducing conditions) TK25, TK14, K-SAM, KGFR, JWS, fibroblast growth factor receptor 2, ECT1, CFD1, CEK3, CD332, BFR-1, BEK, BBDS FGFR2 Protein, Human, Recombinant (alpha IIIb, hFc) RHC-CD-2618 66.3 kDa (predicted) TK25, TK14, K-SAM, KGFR, JWS, fibroblast growth factor receptor 2, FGFR2 +¦(IIIb), ECT1, CFD1, CEK3, CD332, BFR-1, BEK, BBDS FGFR2 Protein, Human, Recombinant (alpha(IIIb), His & Avi), Biotinylated RHC-CD-2730 42.88 kDa (predicted); 70 kDa (reducing conditions TK25, TK14, K-SAM, KGFR, JWS, fibroblast growth factor receptor 2, FGFR2 +¦(IIIb), ECT1, CFD1, CEK3, CD332, BFR-1, BEK, BBDS FGFR2 Protein, Human, Recombinant (beta IIIc, His) RHC-CD-2626 31.2 kDa (predicted) TK25, TK14, K-SAM, KGFR, JWS, fibroblast growth factor receptor 2, FGFR2 Protein, ECT1, CFD1, CEK3, CD332, BFR-1, BEK, BBDS FGFR2 Protein, Human, Recombinant (His & hFc) RHC-CD-2656 67.6 kDa (predicted); 110-120 kDa (reducing condit TK25, TK14, K-SAM, KGFR, JWS, fibroblast growth factor receptor 2, ECT1, CFD1, CEK3, CD332, BFR-1, BEK, BBDS FGFR2 Protein, Mouse, Recombinant (hFc) RHC-CD-2765 54.1 kDa (predicted); 89.9 kDa (reducing condition svs, KGFRTr, KGFR, fibroblast growth factor receptor 2, Fgfr-7, Fgfr7, Fgfr-2, Bek, AW556123, AU043015 FGFR2 Protein, Mouse, Recombinant (His) RHC-CD-2537 28.5 kDa (predicted); 52.3 kDa (reducing condition svs, KGFRTr, KGFR, fibroblast growth factor receptor 2, Fgfr-7, Fgfr7, Fgfr-2, Bek, AW556123, AU043015 FGFR2IIIb Protein, Human, Recombinant (aa 22-378, hFc) RHC-ENZY-0462 85-120 kDa (reducing condition) KGFR, FGFR2IIIb, FGFR2b, FGFR2 +¦, FGFR2 beta, FGFR2, FGF R2b, CD332, BFR-1 FGFR2IIIb Protein, Human, Recombinant (hFc) RHC-CD-2670 70-90 kDa (reducing condition) KGFR, FGFR2IIIb, FGFR2b, FGFR2 +¦, FGFR2 beta, FGFR2, FGF R2b, CD332, BFR-1 FGFR3 alpha (IIIb) Protein, Human, Recombinant (His & Avi) RHC-CD-2630 41.4 kDa (predicted). Due to glycosylation, the pr JTK4, HSFGFR3EX, FGFR3, FGFR2 +¦(IIIb), FGF R3, EC 2.7.10, CEK2, CEK, CD333, ACH FGFR3 alpha (IIIb) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2806 41.4 kDa (predicted). Due to glycosylation, the pr JTK4, HSFGFR3EX, FGFR3, FGFR2 +¦(IIIb), FGF R3, EC 2.7.10, CEK2, CEK, CD333, ACH FGFR3 alpha (IIIb) Protein, Mouse, Recombinant (His) RHC-CD-2565 37.09 kDa (predicted). Due to glycosylation, the p JTK4, HSFGFR3EX, FGFR3, FGFR2 +¦(IIIb), FGF R3, EC 2.7.10, CEK2, CEK, CD333, ACH FGFR3 alpha (IIIc) Protein, Human, Recombinant (His & Avi) RHC-CD-2564 41.1 kDa (predicted). Due to glycosylation, the pr JTK4, HSFGFR3EX, FGFR3 +¦ (IIIc), FGFR3, FGF R3, EC 2.7.10, CEK2, CEK, CD333, ACH FGFR3 alpha (IIIc) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2628 41.1 kDa (predicted). Due to glycosylation, the pr JTK4, HSFGFR3EX, FGFR3 +¦ (IIIc), FGFR3, FGF R3, EC 2.7.10, CEK2, CEK, CD333, ACH FGFR3 beta (IIIb) Protein, Human, Recombinant (His & Avi) RHC-CD-2621 30.5 kDa (predicted). Due to glycosylation, the pr JTK4, HSFGFR3EX, FGFR3 +¦ (IIIb), FGFR3, FGF R3, EC 2.7.10, CEK2, CEK, CD333, ACH FGFR3 beta (IIIb) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2568 30.5 kDa (predicted). Due to glycosylation, the pr JTK4, HSFGFR3EX, FGFR3 +¦ (IIIb), FGFR3, FGF R3, EC 2.7.10, CEK2, CEK, CD333, ACH FGFR3 beta (IIIc) Protein, Human, Recombinant (His & Avi) RHC-CD-2629 30.1 kDa (predicted). Due to glycosylation, the pr JTK4, HSFGFR3EX, FGFR3 +¦ (IIIc), FGFR3, FGF R3, EC 2.7.10, CEK2, CEK, CD333, ACH FGFR3 beta (IIIc) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2758 30.1 kDa (predicted). Due to glycosylation, the pr JTK4, HSFGFR3EX, FGFR3 +¦ (IIIc), FGFR3, FGF R3, EC 2.7.10, CEK2, CEK, CD333, ACH FGFR3 Protein, Mouse, Recombinant (His) RHC-CD-2741 37 kDa (predicted); 70-80 kDa (reducing condition, sam3, Mfr3, HBGFR, FR3, Flg-2, fibroblast growth factor receptor 3, Fgfr-3, CD333 FGFR4 beta Protein, Human, Recombinant (His & Avi) RHC-CD-2753 26.90 kDa (predicted). Due to glycosylation, the p TKF, JTK2, FGFR4 +¦, FGFR4 beta, FGFR-4, FGFR4, FGF R4, CD334 FGFR4 beta Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2576 26.90 kDa (predicted). Due to glycosylation, the p TKF, JTK2, FGFR4 +¦, FGFR4 beta, FGFR-4, FGFR4, FGF R4, CD334 FGFR4 Protein, Human, Recombinant (His & Avi), Biotinylated RHC-CD-2577 41.4 kDa (predicted). Due to glycosylation, the pr TKF, MGC20292, JTK2, FGFR-4, FGFR4, FGF R4, CD334 FGFRL1 Protein, Human, Recombinant (His) RHC-ENZY-0690 65 kDa (reducing condition) Fibroblast Growth Factor Receptor-Like 1, Fibroblast Growth Factor Receptor 5, FHFR, FGFR-Like Protein, FGFRL1, FGFR-5, FGFR5, FGF Receptor-Like Protein 1, FGF Homologous Factor Receptor FGL1 Protein (Primary Amine Labeling), Human, Recombinant (hFc), Biotinylated RHC-ICP-0206 54.8 kDa (predicted). Due to glycosylation, the pr LFIRE-1, Lag3 ligand, HP-041, HFREP-1, HFREP1, Hepassocin, FGL-1, FGL1 FHIT Protein, Mouse, Recombinant (His) RHC-ENZY-1258 21.1 kDa (predicted) Fragile histidine triad protein, Fhit, Dinucleosidetriphosphatase, Diadenosine 5, 5-P1, P3-triphosphate hydrolase, Bis(5-adenosyl)-triphosphatase, AP3A hydrolase, Adenylylsulfate-ammonia adenylyltransferase, Adenylylsulfatase, Adenosine 5-m FIBRACILLIN CAS:51154-48-4 Trade Name: (2S,5R,6R)-6-[[(2R)-2-[[2-(4-chlorophenoxy)-2-methylpropanoyl]amino]-2-phenylacetyl]amino]-3,3-dimet Formula: C26H28ClN3O6S ACM51154484 546.041 Fibracillinum, Fibracilina, Fibracillin, Fibracilline, Fibracillin [INN], UNII-VSM36G5OTK, Fibracilina [INN-Spanish], Fibracilline [INN-French], Fibracillinum [INN-Latin], CID68683, EINECS 257-021-5, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carb Fibronectin Protein, Human, Recombinant (aa 607-1265, His) RHC-OTH-0245 73.2 kDa (predicted); 94.1 kDa (reducing condition MSF, LETS, GFND2, GFND, FNZ, FN, FINC, fibronectin 1, ED-B, CIG |